import type { BlogArticle } from '../blog-types';

export const article: BlogArticle = {
  slug: "longevity-peptide-stack-2026-research-guide",
  title: "Longevity Peptide Stack 2026: Research Protocol Guide",
  description:
    "A protocol-focused guide for researchers studying peptide combinations targeting the hallmarks of aging. Covers epitalon, SS-31, GHK-Cu, NAD+, study design principles, and biomarker selection.",
  category: "Longevity Research",
  readMinutes: 13,
  publishedAt: "2026-06-03",
  ogImage: "/og-image.jpg",
  body: [
    {
      type: "disclaimer",
      text: "Research chemicals for licensed researchers and scientific educators only. Not for human consumption.",
    },
    {
      type: "paragraph",
      text: "Designing a longevity peptide research protocol requires integrating compound-specific pharmacology with the broader systems biology of aging. This guide provides a protocol-focused framework for researchers building multi-compound longevity studies, drawing on the published literature for each key compound.",
    },
    {
      type: "heading",
      text: "Hallmarks-Based Protocol Design",
    },
    {
      type: "paragraph",
      text: "The most rigorous longevity research protocols are organized around the hallmarks of aging framework. Rather than asking 'which peptide reverses aging?', the better question is: 'Which hallmarks are we targeting, and what endpoints will we measure?' This reframes protocol design around testable biological hypotheses.",
    },
    {
      type: "table",
      headers: ["Hallmark", "Target Peptide(s)", "Measurable Endpoint"],
      rows: [
        ["Telomere attrition", "Epitalon", "Telomere length (qPCR), telomerase activity"],
        ["Mitochondrial dysfunction", "SS-31, NAD+", "ATP production, ROS levels, ΔΨm"],
        ["Cellular senescence", "GHK-Cu", "p16/p21 expression, SASP markers"],
        ["Immune senescence", "Thymosin alpha-1", "T-cell subset ratios, NK cytotoxicity"],
        ["Inflammation (inflammaging)", "BPC-157, GHK-Cu", "IL-6, TNF-α, CRP"],
      ],
    },
    {
      type: "heading",
      text: "Epitalon in Aging Research",
    },
    {
      type: "paragraph",
      text: "Epitalon is primarily studied in models of replicative senescence and telomere biology. The most reproducible protocols in the published literature use subcutaneous administration over 10–20 day cycles. Key endpoints include TERT mRNA expression, telomere length by qPCR or FISH, and proliferative capacity of primary cell cultures.",
    },
    {
      type: "heading",
      text: "SS-31 Protocol Design",
    },
    {
      type: "paragraph",
      text: "SS-31 (Elamipretide) is most commonly studied via subcutaneous injection in rodent models of mitochondrial dysfunction. Research protocols targeting the aging mitochondrial phenotype typically use daily administration for 4–8 weeks in aged animals (18–24 months in mice). Endpoints: mitochondrial respiration (Seahorse assay), ATP/ADP ratio, cardiolipin quantification, and electron microscopy for cristae morphology.",
    },
    {
      type: "heading",
      text: "GHK-Cu Dosing and Application",
    },
    {
      type: "paragraph",
      text: "GHK-Cu is notable for its dose-response relationship: lower concentrations (picomolar to nanomolar range) consistently show the clearest biological activity in vitro. In in vivo wound healing and anti-aging models, subcutaneous and topical routes are both documented. Researchers should consider the application route carefully, as systemic and local effects may differ substantially.",
    },
    {
      type: "heading",
      text: "Combination Stack Considerations",
    },
    {
      type: "paragraph",
      text: "When running multi-compound longevity protocols, key practical considerations include: staggering administration times to distinguish compound-specific effects from interaction effects, selecting a primary endpoint for power calculations while measuring secondary endpoints exploratorily, and choosing study duration based on the slowest-acting compound (telomere-focused endpoints need months; acute mitochondrial endpoints may resolve in weeks).",
    },
    {
      type: "heading",
      text: "Biomarker Selection",
    },
    {
      type: "paragraph",
      text: "Beyond compound-specific endpoints, general aging biomarkers provide context for longevity protocol research. Epigenetic clocks (DNA methylation-based), inflammatory panels (IL-6, TNF-α, CRP), metabolic markers (insulin sensitivity indices, glucose), and functional measures (grip strength, maze performance, exercise capacity) collectively provide a more complete picture of aging phenotype change than any single biomarker.",
    },
    {
      type: "callout",
      text: "Nexphoria supplies epitalon, SS-31, GHK-Cu, and thymosin alpha-1 with batch-specific COAs, third-party HPLC and MS testing, and cold-chain shipping to preserve compound integrity.",
    },
  ],
};
